Correlation Between GM and Acticor Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GM and Acticor Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Acticor Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Acticor Biotech SAS, you can compare the effects of market volatilities on GM and Acticor Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Acticor Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Acticor Biotech.

Diversification Opportunities for GM and Acticor Biotech

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between GM and Acticor is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Acticor Biotech SAS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acticor Biotech SAS and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Acticor Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acticor Biotech SAS has no effect on the direction of GM i.e., GM and Acticor Biotech go up and down completely randomly.

Pair Corralation between GM and Acticor Biotech

Allowing for the 90-day total investment horizon GM is expected to generate 1.73 times less return on investment than Acticor Biotech. But when comparing it to its historical volatility, General Motors is 6.58 times less risky than Acticor Biotech. It trades about 0.11 of its potential returns per unit of risk. Acticor Biotech SAS is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  290.00  in Acticor Biotech SAS on September 3, 2024 and sell it today you would lose (261.00) from holding Acticor Biotech SAS or give up 90.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.41%
ValuesDaily Returns

General Motors  vs.  Acticor Biotech SAS

 Performance 
       Timeline  
General Motors 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in General Motors are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, GM displayed solid returns over the last few months and may actually be approaching a breakup point.
Acticor Biotech SAS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Acticor Biotech SAS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Acticor Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

GM and Acticor Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GM and Acticor Biotech

The main advantage of trading using opposite GM and Acticor Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Acticor Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acticor Biotech will offset losses from the drop in Acticor Biotech's long position.
The idea behind General Motors and Acticor Biotech SAS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon